Immunosuppression: Coronavirus

(asked on 28th February 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how an immunocompromised person who tests positive for covid-19 can access one of the covid-19 treatments.


Answered by
Maggie Throup Portrait
Maggie Throup
This question was answered on 7th March 2022

In England, 1.3 million of the highest risk patients are eligible to receive the monoclonal antibody sotrovimab or antiviral drugs paxlovid, molnupiravir or remdesivir. Eligible patients who receive a positive polymerase chain reaction (PCR) or lateral flow device test result will be contacted by a clinician from a COVID Medicines Delivery Unit to discuss treatment suitability. The clinician will be responsible for assessing the patient and deciding which treatment option is most appropriate for the patient and their existing condition.

In addition, over 20 million people are eligible for the antiviral molnupiravir through the PANORAMIC national study. This study is open to individuals in the United Kingdom who have received a positive PCR test, are aged 50 years old and over or are aged 18 to 49 years old with an underlying medical condition that can increase the risk of developing severe COVID-19.

Reticulating Splines